Vogue Commercial Co. Ltd Balance Sheet-Thyrocare Technologies Ltd | BFSL

BALANCE SHEET

You can view the balance sheet for the last 5 years.
Thyrocare Technologies Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
No. of Equity Shares (in Lacs)529.93529.53529.30529.03528.71
      
EQUITIES AND LIABILITIES     
SHAREHOLDER'S FUNDS     
Equity Share Capital52.9952.9552.9352.9052.87
Total Share Capital52.9952.9552.9352.9052.87
      
Reserves and Surplus493.76473.82476.84470.23371.46
Total Reserves and Surplus493.76473.82476.84470.23371.46
Employees Stock Options0.000.004.533.442.94
Total Shareholders Funds546.75526.77534.30526.57427.27
Minority Interest0.300.860.920.000.00
      
NON-CURRENT LIABILITIES     
Long Term Borrowings0.0010.910.000.000.00
Deferred Tax Liabilities [Net]0.000.000.980.604.39
Other Long Term Liabilities16.9211.8016.1215.705.45
Long Term Provisions6.943.063.300.2713.58
Total Non-Current Liabilities23.8625.7720.4016.5723.42
      
CURRENT LIABILITIES     
Short Term Borrowings0.0010.690.000.000.00
Trade Payables76.2140.1123.9916.5325.01
Other Current Liabilities44.6336.8749.0741.3066.71
Short Term Provisions1.002.814.046.693.39
Total Current Liabilities121.8490.4877.1064.5295.11
      
Total Capital And Liabilities692.75643.88632.72607.66545.80
      
ASSETS     
NON-CURRENT ASSETS     
Tangible Assets184.16201.16192.82183.84151.80
Intangible Assets4.840.690.790.830.97
Capital Work-In-Progress14.152.551.612.958.28
Fixed Assets203.15204.40195.22187.62161.05
Goodwill On Consolidation108.21104.03100.28100.28100.28
Non-Current Investments24.1725.6222.1020.9221.10
Deferred Tax Assets [Net]8.5314.8212.276.495.63
Long Term Loans And Advances0.000.000.000.002.89
Other Non-Current Assets10.9716.5029.9122.3316.71
Total Non-Current Assets355.03365.37359.78337.64307.66
      
      
CURRENT ASSETS     
Current Investments137.36136.75122.30125.21104.49
Inventories46.5447.5227.6724.5323.36
Trade Receivables73.0043.4785.1293.2044.68
Cash And Cash Equivalents54.4839.8928.4713.9115.73
Short Term Loans And Advances0.000.000.000.060.60
OtherCurrentAssets26.3410.889.3813.1149.28
Total Current Assets337.72278.51272.94270.02238.14
      
Total Assets692.75643.88632.72607.66545.80
      
OTHER INFORMATION     
      
CONTINGENT LIABILITIES, COMMITMENTS     
Contingent Liabilities216.83299.65404.97156.92129.81
      
BONUS DETAILS     
Bonus Equity Share Capital36.7436.7436.7436.7436.74
      
CURRENT INVESTMENTS     
Current Investments Quoted Market Value137.36136.75122.30125.21104.49
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
No. of Equity Shares (in Lacs)529.93
  
EQUITIES AND LIABILITIES 
SHAREHOLDER'S FUNDS 
Equity Share Capital52.99
Total Share Capital52.99
Reserves and Surplus493.76
Total Reserves and Surplus493.76
Employees Stock Options0.00
Total Shareholders Funds546.75
Minority Interest0.30
NON-CURRENT LIABILITIES 
Long Term Borrowings0.00
Deferred Tax Liabilities [Net]0.00
Other Long Term Liabilities16.92
Long Term Provisions6.94
Total Non-Current Liabilities23.86
CURRENT LIABILITIES 
Short Term Borrowings0.00
Trade Payables76.21
Other Current Liabilities44.63
Short Term Provisions1.00
Total Current Liabilities121.84
Total Capital And Liabilities692.75
ASSETS 
NON-CURRENT ASSETS 
Tangible Assets184.16
Intangible Assets4.84
Capital Work-In-Progress14.15
Fixed Assets203.15
Goodwill On Consolidation108.21
Non-Current Investments24.17
Deferred Tax Assets [Net]8.53
Long Term Loans And Advances0.00
Other Non-Current Assets10.97
Total Non-Current Assets355.03
CURRENT ASSETS 
Current Investments137.36
Inventories46.54
Trade Receivables73.00
Cash And Cash Equivalents54.48
Short Term Loans And Advances0.00
OtherCurrentAssets26.34
Total Current Assets337.72
Total Assets692.75
OTHER INFORMATION 
CONTINGENT LIABILITIES, COMMITMENTS 
Contingent Liabilities216.83
BONUS DETAILS 
Bonus Equity Share Capital36.74
CURRENT INVESTMENTS 
Current Investments Quoted Market Value137.36